哺乳动物的癌症风险
Orsolya Vincze1,2,3,4, Fernando Colchero5,6,7, Jean-Francois Lemaître8
1CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France. vincze.orsolya@ecolres.hu.
Nature
|December 23, 2021
概括
哺乳动物的癌症死亡风险与身体大小和寿命无关, 肉食饮食与更高的癌症风险有关, 这表明饮食和进化塑造了癌症抵抗力.
科学领域:
- 进化生物学
- 癌症研究
- 动物学
背景情况:
- 癌症在动物中很常见,理论预测较大,寿命较长的物种由于更多的细胞分裂而面临更高的风险.
- 佩托的悖论强调了不同物种体型/寿命与癌症风险之间缺乏相关性.
- 不同的非模型物种癌症风险的经验数据很少.
研究的目的:
- 通过分析哺乳动物种类的癌症相关死亡率来调查Peto的悖论.
- 确定哺乳动物体型,寿命和癌症风险之间的关系.
- 在哺乳动物生命树上探索影响癌症死亡率的因素.
主要方法:
- 在191种动物园的110,148种成年哺乳动物中编制了与癌症相关的死亡数据库.
- 将年龄控制的癌症死亡率映射到哺乳动物的进化树上.
- 分析了癌症死亡率,体质,寿命,饮食和基因组之间的相关性.
主要成果:
- 在哺乳动物中广泛发生癌症,死亡率有显著的不同.
- 发现癌症死亡风险在很大程度上独立于物种的体重和成年寿命.
- 在食肉哺乳动物中发现与癌症相关的死亡率较高,
结论:
- 提供了明确的证据支持皮托悖论的体型和寿命组成部分.
- 突出了生命历史进化的关键作用,
- 进一步了解自然抗癌防御及其进化驱动因素.
相关概念视频
Mouse Models of Cancer Study
5.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Mutagenicity and Carcinogenicity
1.5K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K
Cancer
50.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.6K
Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478


